Publications:

---

Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish.

Frontiers In Cardiovascular Medicine

VL Vedder, Z Aherrahrou, J Erdmann

Publication Date: 2020

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 32714944

View BVdb publication page

---

Application of Genetically Engineered Pigs in Biomedical Research.

Genes

M Hryhorowicz, D Lipiński, S Hryhorowicz, A Nowak-Terpiłowska, N Ryczek, J Zeyland

Publication Date: 2020-06-19

Variant appearance in text: PCSK9: D374Y

PMID: 32575461

View BVdb publication page

---

Effects of castration on atherosclerosis in Yucatan minipigs with genetic hypercholesterolemia.

Plos One

JT Shim, N Schmidt, P Nogales, T Larsen, CB Sørensen, JF Bentzon

Publication Date: 2020

Variant appearance in text: PCSK9: D374Y

PMID: 32502216

View BVdb publication page

---

How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs.

Molecules (Basel, Switzerland)

M Garofalo, G Grazioso, A Cavalli, J Sgrignani

Publication Date: 2020-04-10

Variant appearance in text: PCSK9: D374Y

PMID: 32290224

View BVdb publication page

---

Molecular diagnosis methods in familial hypercholesterolemia.

Anatolian Journal Of Cardiology

V Moldovan, C Banescu, M Dobreanu

Publication Date: 2020-02

Variant appearance in text: PCSK9: D374Y; rs137852912

PMID: 32120369

View BVdb publication page

---

In Silico Insights into Protein-protein Interaction Disruptive Mutations in the PCSK9-LDLR complex.

International Journal Of Molecular Sciences

WR Martin, FC Lightstone, F Cheng

Publication Date: 2020-02-25

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 32106405

View BVdb publication page

---

Modelling of atherosclerosis in genetically modified animals.

American Journal Of Translational Research

NV Mushenkova, VI Summerhill, YY Silaeva, AV Deykin, AN Orekhov

Publication Date: 2019

Variant appearance in text: PCSK9: D374Y

PMID: 31497187

View BVdb publication page

---

Lupin Peptide T9 (GQEQSHQDEGVIVR) Modulates the Mutant PCSK9D374Y Pathway: in vitro Characterization of its Dual Hypocholesterolemic Behavior.

Nutrients

C Lammi, C Bollati, D Lecca, MP Abbracchio, A Arnoldi

Publication Date: 2019-07-20

Variant appearance in text: PCSK9: D374Y

PMID: 31330826

View BVdb publication page

---

An update on the tools for creating transgenic animal models of human diseases - focus on atherosclerosis.

Brazilian Journal Of Medical And Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas

AS Volobueva, AN Orekhov, AV Deykin

Publication Date: 2019

Variant appearance in text: PCSK9: D374Y

PMID: 31038578

View BVdb publication page

---

Inhibition of PCSK9D374Y/LDLR Protein-Protein Interaction by Computationally Designed T9 Lupin Peptide.

Acs Medicinal Chemistry Letters

C Lammi, J Sgrignani, G Roda, A Arnoldi, G Grazioso

Publication Date: 2019-04-11

Variant appearance in text: PCSK9: D374Y

PMID: 30996774

View BVdb publication page

---

Updates on Approaches for Studying Atherosclerosis.

Arteriosclerosis, Thrombosis, And Vascular Biology

C Wu, A Daugherty, HS Lu

Publication Date: 2019-04

Variant appearance in text: PCSK9: D374Y

PMID: 30917052

View BVdb publication page

---

Targeting proprotein convertase subtilisin/kexin type 9 in mice and monkeys.

Current Opinion In Lipidology

Y Wang, M Ma, JA Wang, A Daugherty, HS Lu

Publication Date: 2019-04

Variant appearance in text: PCSK9: D374Y

PMID: 30844857

View BVdb publication page

---

Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells.

Nature Communications

T Hadi, L Boytard, M Silvestro, D Alebrahim, S Jacob, J Feinstein, K Barone, W Spiro, S Hutchison, R Simon, D Rateri, F Pinet, D Fenyo, M Adelman, KJ Moore, HK Eltzschig, A Daugherty, B Ramkhelawon

Publication Date: 2018-11-27

Variant appearance in text: PCSK9: D374Y

PMID: 30479344

View BVdb publication page

---

Cell-associated heparin-like molecules modulate the ability of LDL to regulate PCSK9 uptake.

Journal Of Lipid Research

AM Galvan, JS Chorba

Publication Date: 2019-01

Variant appearance in text: PCSK9: D374Y

PMID: 30463987

View BVdb publication page

---

Biodynamics: A novel quasi-first principles theory on the fundamental mechanisms of cellular function/dysfunction and the pharmacological modulation thereof.

Plos One

G Selvaggio, RA Pearlstein

Publication Date: 2018

Variant appearance in text: PCSK9: D374Y

PMID: 30383749

View BVdb publication page

---

Blending Gagne's Instructional Model with Peyton's Approach to Design an Introductory Bioinformatics Lesson Plan for Medical Students: Proof-of-Concept Study.

Jmir Medical Education

R Tambi, R Bayoumi, P Lansberg, Y Banerjee

Publication Date: 2018-10-25

Variant appearance in text: PCSK9: D374Y

PMID: 30361192

View BVdb publication page

---

Neurovascular dysfunction in vascular dementia, Alzheimer's and atherosclerosis.

Bmc Neuroscience

O Shabir, J Berwick, SE Francis

Publication Date: 2018-10-17

Variant appearance in text: PCSK9: D374Y

PMID: 30333009

View BVdb publication page

---

The Emerging Role of PCSK9 Inhibitors in Preventive Cardiology.

European Cardiology

RN Pitts, RH Eckel

Publication Date: 2014-12

Variant appearance in text: PCSK9: D374Y

PMID: 30310488

View BVdb publication page

---

Case-control study on PCSK9 R496W (rs374603772) and D374Y (rs137852912) mutations in Turkish patients with primary dyslipidemia.

Anatolian Journal Of Cardiology

Z Eroğlu, A Tetik Vardarlı, Z Düzgün, C Gündüz, V Bozok Çetintaş, M Kayıkçıoğlu

Publication Date: 2018-05

Variant appearance in text: PCSK9: D374Y; rs137852912

PMID: 29724976

View BVdb publication page

---

Ossabaw Pigs With a PCSK9 Gain-of-Function Mutation Develop Accelerated Coronary Atherosclerotic Lesions: A Novel Model for Preclinical Studies.

Journal Of The American Heart Association

F Yuan, L Guo, KH Park, JR Woollard, K Taek-Geun, K Jiang, T Melkamu, B Zang, SL Smith, SC Fahrenkrug, FD Kolodgie, A Lerman, R Virmani, LO Lerman, DF Carlson

Publication Date: 2018-03-23

Variant appearance in text: PCSK9: D374Y

PMID: 29572319

View BVdb publication page

---

Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels.

International Journal Of Molecular Sciences

C Jiang, H Nischal, H Sun, L Li, Y Cao, P Wei, JY Chang, BB Teng

Publication Date: 2018-02-24

Variant appearance in text: PCSK9: D374Y

PMID: 29495280

View BVdb publication page

---

RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis.

Arteriosclerosis, Thrombosis, And Vascular Biology

XB Cui, JN Luan, K Dong, S Chen, Y Wang, WT Watford, SY Chen

Publication Date: 2018-04

Variant appearance in text: PCSK9: D374Y

PMID: 29449334

View BVdb publication page

---

Genetically engineered pigs as models for human disease.

Disease Models & Mechanisms

C Perleberg, A Kind, A Schnieke

Publication Date: 2018-01-22

Variant appearance in text: PCSK9: D374Y

PMID: 29419487

View BVdb publication page

---

Computational Study of PCSK9-EGFA Complex with Effective Polarizable Bond Force Field.

Frontiers In Molecular Biosciences

J Chen, L Duan, C Ji, JZH Zhang

Publication Date: 2017

Variant appearance in text: PCSK9: D374Y

PMID: 29379787

View BVdb publication page

---

Stepwise processing analyses of the single-turnover PCSK9 protease reveal its substrate sequence specificity and link clinical genotype to lipid phenotype.

The Journal Of Biological Chemistry

JS Chorba, AM Galvan, KM Shokat

Publication Date: 2018-02-09

Variant appearance in text: PCSK9: D374Y

PMID: 29259136

View BVdb publication page

---

Peripheral vascular atherosclerosis in a novel PCSK9 gain-of-function mutant Ossabaw miniature pig model.

Translational Research : The Journal Of Laboratory And Clinical Medicine

AF Hedayat, KH Park, TG Kwon, JR Woollard, K Jiang, DF Carlson, A Lerman, LO Lerman

Publication Date: 2018-02

Variant appearance in text: PCSK9: D374Y

PMID: 29175268

View BVdb publication page

---

Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia.

Scientific Reports

MD Di Taranto, A Benito-Vicente, C Giacobbe, KB Uribe, P Rubba, A Etxebarria, O Guardamagna, M Gentile, C Martín, G Fortunato

Publication Date: 2017-11-10

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 29127338

View BVdb publication page

---

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol.

Global Cardiology Science & Practice

NG Seidah

Publication Date: 2017-03-31

Variant appearance in text: PCSK9: D374Y

PMID: 28971102

View BVdb publication page

---

Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.

Ebiomedicine

A Hyrina, AD Olmstead, P Steven, M Krajden, E Tam, F Jean

Publication Date: 2017-09

Variant appearance in text: PCSK9: D374Y

PMID: 28864162

View BVdb publication page

---

Increased half-life and enhanced potency of Fc-modified human PCSK9 monoclonal antibodies in primates.

Plos One

Y Shen, H Li, L Zhao, G Li, B Chen, Q Guo, B Gao, J Wu, T Yang, L Jin, Y Su

Publication Date: 2017

Variant appearance in text: PCSK9: D374Y

PMID: 28817679

View BVdb publication page

---

PCSK 9 gain-of-function mutations (R496W and D374Y) and clinical cardiovascular characteristics in a cohort of Turkish patients with familial hypercholesterolemia.

Anatolian Journal Of Cardiology

E Kaya, M Kayıkçıoğlu, A Tetik Vardarlı, Z Eroğlu, S Payzın, L Can

Publication Date: 2017-10

Variant appearance in text: PCSK9: D374Y; rs137852912

PMID: 28777095

View BVdb publication page

---

Whole-Exomes Sequencing Delineates Gene Variants Profile in a Young Saudi Male with Familial Hypercholesterolemia: Case Report.

Journal Of Clinical And Diagnostic Research : Jcdr

E Nuglozeh

Publication Date: 2017-06

Variant appearance in text: PCSK9: 1120G>T; Asp374Tyr

PMID: 28764195

View BVdb publication page

---

Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9.

Plos One

R Romagnuolo, CA Scipione, SM Marcovina, M Gemin, NG Seidah, MB Boffa, ML Koschinsky

Publication Date: 2017

Variant appearance in text: PCSK9: D374Y

PMID: 28750079

View BVdb publication page

---

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.

European Journal Of Preventive Cardiology

I Pećin, ML Hartgers, GK Hovingh, R Dent, Ž Reiner

Publication Date: 2017-09

Variant appearance in text: PCSK9: D374Y

PMID: 28644091

View BVdb publication page

---

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.

Atherosclerosis

M Sharifi, E Higginson, S Bos, A Gallivan, D Harvey, KW Li, A Abeysekera, A Haddon, H Ashby, KE Shipman, JA Cooper, M Futema, JE Roeters van Lennep, EJG Sijbrands, M Labib, D Nair, SE Humphries

Publication Date: 2017-08

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 28549500

View BVdb publication page

---

APP, APLP2 and LRP1 interact with PCSK9 but are not required for PCSK9-mediated degradation of the LDLR in vivo.

Biochimica Et Biophysica Acta. Molecular And Cell Biology Of Lipids

T Fu, Y Guan, J Xu, Y Wang

Publication Date: 2017-09

Variant appearance in text: PCSK9: D374Y

PMID: 28495363

View BVdb publication page

---

Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.

Basic Research In Cardiology

S Glerup, R Schulz, U Laufs, KD Schlüter

Publication Date: 2017-05

Variant appearance in text: PCSK9: D374Y

PMID: 28439730

View BVdb publication page

---

Genetic Architecture of Familial Hypercholesterolaemia.

Current Cardiology Reports

M Sharifi, M Futema, D Nair, SE Humphries

Publication Date: 2017-05

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 28405938

View BVdb publication page

---

A wild-type mouse-based model for the regression of inflammation in atherosclerosis.

Plos One

M Peled, H Nishi, A Weinstock, TJ Barrett, F Zhou, A Quezada, EA Fisher

Publication Date: 2017

Variant appearance in text: PCSK9: D374Y

PMID: 28291840

View BVdb publication page

---

Selection of DNA aptamers with two modified bases.

Proceedings Of The National Academy Of Sciences Of The United States Of America

BN Gawande, JC Rohloff, JD Carter, I von Carlowitz, C Zhang, DJ Schneider, N Janjic

Publication Date: 2017-03-14

Variant appearance in text: PCSK9: D374Y

PMID: 28265062

View BVdb publication page

---

The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA.

The Journal Of Biological Chemistry

D Susan-Resiga, E Girard, RS Kiss, R Essalmani, J Hamelin, MC Asselin, Z Awan, C Butkinaree, A Fleury, A Soldera, YL Dory, A Baass, NG Seidah

Publication Date: 2017-02-03

Variant appearance in text: PCSK9: D374Y

PMID: 27998977

View BVdb publication page

---

Studies of the autoinhibitory segment comprising residues 31-60 of the prodomain of PCSK9: Possible implications for the mechanism underlying gain-of-function mutations.

Molecular Genetics And Metabolism Reports

L Wierød, J Cameron, TB Strøm, TP Leren

Publication Date: 2016-12

Variant appearance in text: PCSK9: D374Y

PMID: 27896130

View BVdb publication page

---

Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.

Arteriosclerosis, Thrombosis, And Vascular Biology

H Lu, DA Howatt, A Balakrishnan, MJ Graham, AE Mullick, A Daugherty

Publication Date: 2016-09

Variant appearance in text: PCSK9: D374Y

PMID: 27470509

View BVdb publication page

---

Translational and Therapeutic Approaches to the Understanding and Treatment of Dyslipidemia.

Arteriosclerosis, Thrombosis, And Vascular Biology

H Zhang, TQ de Aguiar Vallim, C Martel,

Publication Date: 2016-07

Variant appearance in text: PCSK9: D374Y

PMID: 27335468

View BVdb publication page

---

A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification.

Atherosclerosis

C Goettsch, JD Hutcheson, S Hagita, MA Rogers, MD Creager, T Pham, J Choi, AK Mlynarchik, B Pieper, M Kjolby, M Aikawa, E Aikawa

Publication Date: 2016-08

Variant appearance in text: PCSK9: D374Y

PMID: 27318830

View BVdb publication page

---

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.

The Journal Of Biological Chemistry

E Weider, D Susan-Resiga, R Essalmani, J Hamelin, MC Asselin, S Nimesh, Y Ashraf, KL Wycoff, J Zhang, A Prat, NG Seidah

Publication Date: 2016-08-05

Variant appearance in text: PCSK9: D374Y

PMID: 27284008

View BVdb publication page

---

Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain.

Plos One

S Poirier, HA Hamouda, L Villeneuve, A Demers, G Mayer

Publication Date: 2016

Variant appearance in text: PCSK9: D374Y

PMID: 27280970

View BVdb publication page

---

Cardiovascular risk stratification in familial hypercholesterolaemia.

Heart (British Cardiac Society)

M Sharifi, RD Rakhit, SE Humphries, D Nair

Publication Date: 2016-07-01

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 27126396

View BVdb publication page

---

Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.

Plos One

A Ramanathan, V Gusarova, N Stahl, A Gurnett-Bander, CA Kyratsous

Publication Date: 2016

Variant appearance in text: PCSK9: D374Y

PMID: 27115873

View BVdb publication page

---

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.

Cardiovascular Research

H Tavori, I Giunzioni, IM Predazzi, D Plubell, A Shivinsky, J Miles, RM Devay, H Liang, S Rashid, MF Linton, S Fazio

Publication Date: 2016-05-15

Variant appearance in text: PCSK9: D374Y

PMID: 26980204

View BVdb publication page

---

Investigating the Metabolic Syndrome: Contributions of Swine Models.

Toxicologic Pathology

X Zhang, LO Lerman

Publication Date: 2016-04

Variant appearance in text: PCSK9: D374Y

PMID: 26933085

View BVdb publication page

---

The genetic spectrum of familial hypercholesterolemia in south-eastern Poland.

Metabolism: Clinical And Experimental

M Sharifi, M Walus-Miarka, B Idzior-Waluś, MT Malecki, M Sanak, R Whittall, KW Li, M Futema, SE Humphries

Publication Date: 2016-03

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 26892515

View BVdb publication page

---

Vascular endothelial dysfunction and pharmacological treatment.

World Journal Of Cardiology

JB Su

Publication Date: 2015-11-26

Variant appearance in text: PCSK9: D374Y

PMID: 26635921

View BVdb publication page

---

Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia.

Disease Models & Mechanisms

K Si-Tayeb, S Idriss, B Champon, A Caillaud, M Pichelin, L Arnaud, P Lemarchand, C Le May, K Zibara, B Cariou

Publication Date: 2016-01

Variant appearance in text: PCSK9: D374Y

PMID: 26586530

View BVdb publication page

---

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.

Circulation. Cardiovascular Genetics

PN Hopkins, J Defesche, SW Fouchier, E Bruckert, G Luc, B Cariou, B Sjouke, TP Leren, M Harada-Shiba, H Mabuchi, JP Rabès, A Carrié, C van Heyningen, V Carreau, M Farnier, YP Teoh, M Bourbon, MA Kawashiri, A Nohara, H Soran, AD Marais, H Tada, M Abifadel, C Boileau, B Chanu, S Katsuda, I Kishimoto, G Lambert, H Makino, Y Miyamoto, M Pichelin, K Yagi, M Yamagishi, Y Zair, S Mellis, GD Yancopoulos, N Stahl, J Mendoza, Y Du, S Hamon, M Krempf, GD Swergold

Publication Date: 2015-12

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 26374825

View BVdb publication page

---

PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice.

Journal Of Lipid Research

A Roubtsova, A Chamberland, J Marcinkiewicz, R Essalmani, A Fazel, JJ Bergeron, NG Seidah, A Prat

Publication Date: 2015-11

Variant appearance in text: PCSK9: D374Y

PMID: 26323289

View BVdb publication page

---

PCSK9 and triglyceride-rich lipoprotein metabolism.

Journal Of Biomedical Research

I Druce, H Abujrad, TC Ooi

Publication Date: 2015-07-20

Variant appearance in text: PCSK9: D374Y

PMID: 26320603

View BVdb publication page

---

Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9.

The Journal Of Biological Chemistry

QT Le, M Blanchet, NG Seidah, P Labonté

Publication Date: 2015-09-18

Variant appearance in text: PCSK9: D374Y

PMID: 26195630

View BVdb publication page

---

Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other.

The Journal Of Biological Chemistry

C Butkinaree, M Canuel, R Essalmani, S Poirier, S Benjannet, MC Asselin, A Roubtsova, J Hamelin, J Marcinkiewicz, A Chamberland, J Guillemot, G Mayer, SS Sisodia, Y Jacob, A Prat, NG Seidah

Publication Date: 2015-07-24

Variant appearance in text: PCSK9: D374Y

PMID: 26085104

View BVdb publication page

---

PCSK9 regulates apoptosis in human neuroglioma u251 cells via mitochondrial signaling pathways.

International Journal Of Clinical And Experimental Pathology

MX Piao, JW Bai, PF Zhang, YZ Zhang

Publication Date: 2015

Variant appearance in text: PCSK9: D374Y

PMID: 26045785

View BVdb publication page

---

β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells.

The Febs Journal

AE Starr, V Lemieux, J Noad, JI Moore, T Dewpura, A Raymond, M Chrétien, D Figeys, J Mayne

Publication Date: 2015-07

Variant appearance in text: PCSK9: D374Y

PMID: 25913303

View BVdb publication page

---

Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor.

The Journal Of Biological Chemistry

R Romagnuolo, CA Scipione, MB Boffa, SM Marcovina, NG Seidah, ML Koschinsky

Publication Date: 2015-05-01

Variant appearance in text: PCSK9: D374Y

PMID: 25778403

View BVdb publication page

---

Atherosclerosis.

Arteriosclerosis, Thrombosis, And Vascular Biology

H Lu, A Daugherty

Publication Date: 2015-03

Variant appearance in text: PCSK9: D374Y

PMID: 25717174

View BVdb publication page

---

Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9).

Basic Research In Cardiology

R Schulz, KD Schlüter, U Laufs

Publication Date: 2015-03

Variant appearance in text: PCSK9: D374Y

PMID: 25600226

View BVdb publication page

---

On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.

Atherosclerosis

H Tavori, S Rashid, S Fazio

Publication Date: 2015-02

Variant appearance in text: PCSK9: D374Y

PMID: 25544176

View BVdb publication page

---

Accelerating the pace of atherosclerosis research.

Arteriosclerosis, Thrombosis, And Vascular Biology

A Daugherty, I Tabas, DJ Rader

Publication Date: 2015-01

Variant appearance in text: PCSK9: D374Y

PMID: 25520521

View BVdb publication page

---

Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.

Clinical Chemistry

M Futema, S Shah, JA Cooper, K Li, RA Whittall, M Sharifi, O Goldberg, E Drogari, V Mollaki, A Wiegman, J Defesche, MN D'Agostino, A D'Angelo, P Rubba, G Fortunato, M Waluś-Miarka, RA Hegele, M Aderayo Bamimore, R Durst, E Leitersdorf, MT Mulder, JE Roeters van Lennep, EJ Sijbrands, JC Whittaker, PJ Talmud, SE Humphries

Publication Date: 2015-01

Variant appearance in text: PCSK9: D374Y

PMID: 25414277

View BVdb publication page

---

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.

Journal Of Medical Genetics

M Futema, V Plagnol, K Li, RA Whittall, HA Neil, M Seed, , S Bertolini, S Calandra, OS Descamps, CA Graham, RA Hegele, F Karpe, R Durst, E Leitersdorf, N Lench, DR Nair, H Soran, FM Van Bockxmeer, , SE Humphries

Publication Date: 2014-08

Variant appearance in text: PCSK9: 1120G>T; Asp374Tyr

PMID: 24987033

View BVdb publication page

---

Annexin A2 reduces PCSK9 protein levels via a translational mechanism and interacts with the M1 and M2 domains of PCSK9.

The Journal Of Biological Chemistry

K Ly, YG Saavedra, M Canuel, S Routhier, R Desjardins, J Hamelin, J Mayne, C Lazure, NG Seidah, R Day

Publication Date: 2014-06-20

Variant appearance in text: PCSK9: D374Y

PMID: 24808179

View BVdb publication page

---

Isolation and characterization of the circulating truncated form of PCSK9.

Journal Of Lipid Research

B Han, PI Eacho, MD Knierman, JS Troutt, RJ Konrad, X Yu, KM Schroeder

Publication Date: 2014-07

Variant appearance in text: PCSK9: D374Y

PMID: 24776539

View BVdb publication page

---

Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs.

Plos One

BT Davis, XJ Wang, JA Rohret, JT Struzynski, EP Merricks, DA Bellinger, FA Rohret, TC Nichols, CS Rogers

Publication Date: 2014

Variant appearance in text: PCSK9: D374Y

PMID: 24691380

View BVdb publication page

---

The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review).

Biomedical Reports

Q Wu, ZH Tang, J Peng, L Liao, LH Pan, CY Wu, ZS Jiang, GX Wang, LS Liu

Publication Date: 2014-03

Variant appearance in text: PCSK9: D374Y

PMID: 24649090

View BVdb publication page

---

Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation.

Journal Of Virology

GH Syed, H Tang, M Khan, T Hassanein, J Liu, A Siddiqui

Publication Date: 2014-03

Variant appearance in text: PCSK9: D374Y

PMID: 24352472

View BVdb publication page

---

The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.

Biomed Research International

ER de Almeida, EM Reiche, AP Kallaur, T Flauzino, MA Watanabe

Publication Date: 2013

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 24319689

View BVdb publication page

---

Internalized PCSK9 dissociates from recycling LDL receptors in PCSK9-resistant SV-589 fibroblasts.

Journal Of Lipid Research

MA Nguyen, T Kosenko, TA Lagace

Publication Date: 2014-02

Variant appearance in text: PCSK9: D374Y

PMID: 24296664

View BVdb publication page

---

Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases.

Scientifica

N Ferri

Publication Date: 2012

Variant appearance in text: PCSK9: D374Y

PMID: 24278757

View BVdb publication page

---

The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol.

Drug Design, Development And Therapy

S Poirier, G Mayer

Publication Date: 2013

Variant appearance in text: PCSK9: D374Y

PMID: 24115837

View BVdb publication page

---

Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding.

Journal Of Lipid Research

HM Gu, A Adijiang, M Mah, DW Zhang

Publication Date: 2013-12

Variant appearance in text: PCSK9: D374Y

PMID: 24103783

View BVdb publication page

---

Atherosclerosis: cell biology and lipoproteins.

Current Opinion In Lipidology

H Lu, A Daugherty

Publication Date: 2013-10

Variant appearance in text: PCSK9: D374Y

PMID: 24005221

View BVdb publication page

---

Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.

Current Genomics

A Jelassi, M Najah, A Slimani, I Jguirim, MN Slimane, M Varret

Publication Date: 2013-03

Variant appearance in text: PCSK9: D374Y

PMID: 23997648

View BVdb publication page

---

PCSK9 prosegment chimera as novel inhibitors of LDLR degradation.

Plos One

YG Saavedra, J Zhang, NG Seidah

Publication Date: 2013

Variant appearance in text: PCSK9: D374Y

PMID: 23951290

View BVdb publication page

---

Porcine models of accelerated coronary atherosclerosis: role of diabetes mellitus and hypercholesterolemia.

Journal Of Diabetes Research

D Hamamdzic, RL Wilensky

Publication Date: 2013

Variant appearance in text: PCSK9: D374Y

PMID: 23844374

View BVdb publication page

---

Genetic screening for homozygous and heterozygous familial hypercholesterolemia.

The Application Of Clinical Genetics

MC Izar, VA Machado, FA Fonseca

Publication Date: 2010

Variant appearance in text: PCSK9: D374Y

PMID: 23776359

View BVdb publication page

---

The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.

The Application Of Clinical Genetics

I De Castro-Orós, M Pocoví, F Civeira

Publication Date: 2010

Variant appearance in text: PCSK9: D374Y

PMID: 23776352

View BVdb publication page

---

Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.

Circulation

H Tavori, D Fan, JL Blakemore, PG Yancey, L Ding, MF Linton, S Fazio

Publication Date: 2013-06-18

Variant appearance in text: PCSK9: D374Y

PMID: 23690465

View BVdb publication page

---

Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1).

Plos One

M Canuel, X Sun, MC Asselin, E Paramithiotis, A Prat, NG Seidah

Publication Date: 2013

Variant appearance in text: PCSK9: D374Y

PMID: 23675525

View BVdb publication page

---

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.

Atherosclerosis

M Futema, RA Whittall, A Kiley, LK Steel, JA Cooper, E Badmus, SE Leigh, F Karpe, HA Neil, , SE Humphries

Publication Date: 2013-07

Variant appearance in text: PCSK9: Asp374Tyr

PMID: 23669246

View BVdb publication page

---

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations.

Lipids In Health And Disease

J Mayne, TC Ooi, A Raymond, M Cousins, L Bernier, T Dewpura, F Sirois, M Mbikay, J Davignon, M Chrétien

Publication Date: 2013-05-10

Variant appearance in text: PCSK9: D374Y

PMID: 23663650

View BVdb publication page

---

PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment.

Journal Of Lipid Research

K Tveten, TB Strøm, KE Berge, TP Leren

Publication Date: 2013-06

Variant appearance in text: PCSK9: D374Y

PMID: 23509406

View BVdb publication page

---

Low density lipoprotein binds to proprotein convertase subtilisin/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation.

The Journal Of Biological Chemistry

T Kosenko, M Golder, G Leblond, W Weng, TA Lagace

Publication Date: 2013-03-22

Variant appearance in text: PCSK9: D374Y

PMID: 23400816

View BVdb publication page

---

Mutation in the PCSK9 Gene in Omani Arab Subjects with Autosomal Dominant Hypercholesterolemia and its Effect on PCSK9 Protein Structure.

Oman Medical Journal

K Al-Waili, WA Al-Zidi, AR Al-Abri, K Al-Rasadi, HA Al-Sabti, K Shah, A Al-Futaisi, I Al-Zakwani, Y Banerjee

Publication Date: 2013-01

Variant appearance in text: PCSK9: D374Y

PMID: 23386946

View BVdb publication page

---

Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liver.

Neoplasia (New York, N.Y.)

X Sun, R Essalmani, R Day, AM Khatib, NG Seidah, A Prat

Publication Date: 2012-12

Variant appearance in text: PCSK9: D374Y

PMID: 23308045

View BVdb publication page

---

The M2 module of the Cys-His-rich domain (CHRD) of PCSK9 protein is needed for the extracellular low-density lipoprotein receptor (LDLR) degradation pathway.

The Journal Of Biological Chemistry

YG Saavedra, R Day, NG Seidah

Publication Date: 2012-12-21

Variant appearance in text: PCSK9: D374Y

PMID: 23105118

View BVdb publication page

---

c-IAP1 binds and processes PCSK9 protein: linking the c-IAP1 in a TNF-α pathway to PCSK9-mediated LDLR degradation pathway.

Molecules (Basel, Switzerland)

W Xu, L Liu, D Hornby

Publication Date: 2012-10-15

Variant appearance in text: PCSK9: D374Y

PMID: 23085658

View BVdb publication page

---

Low prevalence of mutations in known loci for autosomal dominant hypercholesterolemia in a multiethnic patient cohort.

Circulation. Cardiovascular Genetics

Z Ahmad, B Adams-Huet, C Chen, A Garg

Publication Date: 2012-12

Variant appearance in text: PCSK9: D374Y

PMID: 23064986

View BVdb publication page

---

Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia.

Journal Of Medical Genetics

M Futema, V Plagnol, RA Whittall, HA Neil, , SE Humphries,

Publication Date: 2012-10

Variant appearance in text: PCSK9: 1120G>T; D374Y

PMID: 23054246

View BVdb publication page

---

The PCSK9 decade.

Journal Of Lipid Research

G Lambert, B Sjouke, B Choque, JJ Kastelein, GK Hovingh

Publication Date: 2012-12

Variant appearance in text: PCSK9: D374Y

PMID: 22811413

View BVdb publication page

---

Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR.

Journal Of Lipid Research

Y Wang, Y Huang, HH Hobbs, JC Cohen

Publication Date: 2012-09

Variant appearance in text: PCSK9: D374Y

PMID: 22764087

View BVdb publication page

---

Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Journal Of Lipid Research

S Calandra, P Tarugi, HE Speedy, AF Dean, S Bertolini, CC Shoulders

Publication Date: 2011-11

Variant appearance in text: PCSK9: D374Y

PMID: 21862702

View BVdb publication page

---

Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors.

Journal Of Lipid Research

ØL Holla, J Cameron, K Tveten, TB Strøm, KE Berge, JK Laerdahl, TP Leren

Publication Date: 2011-10

Variant appearance in text: PCSK9: D374Y

PMID: 21771976

View BVdb publication page

---

Alternative transcript annotations:

Transcript	cDNA	Protein	Consequence	Exon	Intron
ENST00000302118.5	c.1120G>T	p.Asp374Tyr	missense_variant	7/12	-
ENST00000490692.1	n.1844G>T	-	non_coding_transcript_exon_variant	4/8	-
ENST00000543384.1	c.520G>T	p.Asp174Tyr	missense_variant	5/10	-
NM_174936.4	c.1120G>T	p.Asp374Tyr	missense_variant	7/12	-
NR_110451.1	n.779G>T	-	non_coding_transcript_exon_variant	5/10	-